Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update Cooke, Graham S et al. The Lancet Gastroenterology & Hepatology, Volume 0, Issue 0  https://www.thelancet.com/journal…

Reflecting on a Decade of Sofosbuvir Use for Hepatitis C Virus Treatment.  Jacobson IM.  Gastroenterol Hepatol (N Y). 2024 Feb;20(2):123-126. PMID: 38414910; PMCID: PMC10895910. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10895910/

Treating Hepatitis C Virus Infection in Jails as an Offset to Declines in Treatment Activity in the Community, New York City, NY, 2014-2020.  Chan J, Akiyama MJ, Julian E, Joseph R, McGahee W, Rosner Z, Yang P, MacDonald R.  AJPM Focus…

Global HCV and HIV Treatment Restrictions Group. Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions.  Marshall AD, Willing AR, Kairouz A, Cunningham EB, Wheeler A, O'Brien N, Perer…

Schweiz. 10 Jahre Schweizer Hepatitis-Strategie Heute vor genau 10 Jahren, am 16. Januar 2014, wurde der Grundstein gelegt für die zivilgesellschaftliche Initiative Schweizer Hepatitis-Strategie.  30 Persönlichkeiten aus Medizin, Wirtschaft…

Gamal Shiha: eliminating hepatitis C. Bull World Health Organ. 2024 Jan 1;102(1):7-8. doi: 10.2471/BLT.24.030124. PMID: 38164338; PMCID: PMC10753282. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10753282/